A grand symphony orchestra plays, but each group of instruments follows its own score without hearing the others. The violins carry the melody of the heart, the cellos the rhythm of the liver, and the woodwinds the pulse of the brain. It sounds disjointed, even though each part is flawless on its own. That's roughly how today's digital twins of health work: precise computer replicas of organs that can't negotiate with each other.

Engineers have proposed a solution — the OmniBioTwin platform, which acts like a conductor with perfect pitch. It layers seven levels of interaction, from collecting sensor data to synchronizing in time and bringing the physician into decision-making. At the core are modular organ twins that exchange signals through explicit "communication operators," like musicians who have finally heard each other. What emerges is not a set of soloists but a unified ensemble.

The approach was validated on a concrete example: the GLP-1 hormone signaling pathway in Alzheimer's disease. The molecular level (protein interactions), cellular level (neuron response), and organ level (changes in the brain) were combined into a single simulation. Previously, these three layers lived in separate programs; now they exchange messages without delay, as if a blood test could instantly recalculate a tomogram.

Such an orchestra of organs is not just a pretty metaphor. When a doctor changes a drug dosage in the computer model, the system automatically recalculates the consequences not only for the liver but also for the brain, heart, and blood vessels. The patient gets not a set of disjointed forecasts but a holistic picture, like a listener who hears a symphony, not a cacophony.